SCHEMBL4259670

SCHEMBL4259670

CC(C)(C)C(NC(=O)O[C@H]1CCOC1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 3/20 0.36
CTSS P25774 2/20 0.36
MLNR O43193 1/20 0.36
ABCB11 O95342 1/20 0.36
LMNA P02545 1/20 0.36
CTSD P07339 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP3A5 P20815 1/20 0.36
CNR1 P21554 1/20 0.36
TBXAS1 P24557 1/20 0.36
ADRA1A P35348 1/20 0.36
MAPK1 P28482 3/20 0.34
PDE4D Q08499 1/20 0.34
CNR2 P34972 2/20 0.32
ACACB O00763 2/20 0.30
NR1H4 Q96RI1 2/20 0.30
GPBAR1 Q8TDU6 1/20 0.30
CA2 P00918 1/20 0.30
P2RX3 P56373 2/20 0.30
P2RX2 Q9UBL9 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL627445 1.00 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL10137338 1.00 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL13757740 1.00 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL627444 1.00 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL8128957 0.89 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL15338646 0.87 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL12401299 0.87 CTSL (0.36) CTSLCTSSMLNRABCB11LMNA
SCHEMBL8141649 0.86 CTSL (0.37) CTSLCTSSMLNRABCB11LMNA
SCHEMBL12401085 0.86 CTSL (0.35) CTSLCTSSMLNRABCB11LMNA
SCHEMBL627872 0.85 CTSL (0.35) CTSLCTSSMLNRABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114958-A1 INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS Vertex Pharmceuticals Incorporated (US) 2009-11-11 EP disclosed
WO-2008106139-A1 INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-04 WO disclosed
EP-1917269-A2 INHIBITORS OF SERINE PROTEASES Vertex Pharmaceuticals Incorporated (US) 2008-05-07 EP disclosed
WO-2007025307-A2 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-03-01 WO disclosed